14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $5.34 $19.02 Monday, 6th May 2024 OTLK stock ended at $8.50. This is 1.16% less than the trading day before Friday, 3rd May 2024. During the day the stock fluctuated 5.44% from a day low at $8.45 to a day high of $8.91.
90 days $17.30 $19.02
52 weeks $16.32 $20.85

Historical Outlook Therapeutics Inc. prices

Date Open High Low Close Volume
Jul 20, 2023 $1.78 $1.85 $1.67 $1.68 1 472 930
Jul 19, 2023 $1.74 $1.82 $1.70 $1.78 2 978 730
Jul 18, 2023 $1.63 $1.74 $1.63 $1.74 833 282
Jul 17, 2023 $1.65 $1.70 $1.63 $1.64 1 454 573
Jul 14, 2023 $1.76 $1.78 $1.65 $1.65 1 632 861
Jul 13, 2023 $1.79 $1.79 $1.70 $1.76 1 782 676
Jul 12, 2023 $1.73 $1.78 $1.71 $1.74 839 310
Jul 11, 2023 $1.74 $1.75 $1.62 $1.73 911 445
Jul 10, 2023 $1.64 $1.75 $1.63 $1.73 946 543
Jul 07, 2023 $1.66 $1.67 $1.61 $1.63 654 776
Jul 06, 2023 $1.74 $1.74 $1.63 $1.67 1 305 949
Jul 05, 2023 $1.74 $1.81 $1.70 $1.73 1 159 567
Jul 03, 2023 $1.75 $1.75 $1.69 $1.71 433 390
Jun 30, 2023 $1.63 $1.74 $1.61 $1.74 1 203 856
Jun 29, 2023 $1.67 $1.67 $1.60 $1.63 726 964
Jun 28, 2023 $1.65 $1.71 $1.62 $1.67 703 348
Jun 27, 2023 $1.58 $1.67 $1.58 $1.65 763 371
Jun 26, 2023 $1.75 $1.75 $1.57 $1.58 1 534 792
Jun 23, 2023 $1.70 $1.80 $1.70 $1.75 3 311 491
Jun 22, 2023 $1.74 $1.78 $1.72 $1.73 790 128
Jun 21, 2023 $1.75 $1.77 $1.68 $1.75 1 471 266
Jun 20, 2023 $1.84 $1.84 $1.72 $1.77 2 042 159
Jun 16, 2023 $1.81 $1.82 $1.70 $1.81 1 508 991
Jun 15, 2023 $1.66 $1.86 $1.66 $1.78 3 267 954
Jun 14, 2023 $1.64 $1.70 $1.62 $1.68 1 204 391
Click to get the best stock tips daily for free!

About Outlook Therapeutics Inc.

Outlook Therapeutics. Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases. Outlook Therapeutics, Inc. has collaboration and lice... OTLK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT